JPRN-UMIN000014269已完成未知
Concurrent use of Sr-89 chloride with bone-modifying agent(denosumab, zoledronic acid) is safe and effective for breast cancer patients with painful bone metastases - Concurrent use of Sr-89 chloride with bone-modifying agent is safe and effective for breast cancer patients with painful bone metastases
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1. a case indicated chemotherapy 2. a case that has other cancer 3. a case that has grave complication 4. a case that has grave bone marrow suppression 5. a case that has grave renal dysfunction 6. a case that has invasive dental treatment 7. a woman that is pregnant, breast-feed and may be pregnant
研究者
相似试验
已完成
2 期
Effect of Strontium-89 on painful bone metastases in zoledronic acid received patients with prostate cancerProstate CancerJPRN-UMIN000004718Keio University Shool of Medicine Department of Urology10
已完成
2 期
A Trial of Strontium +/- Cisplatin for the Palliation of Bone Pain Secondary to Hormone Refractory Prostate CancerHormone Refractory Prostate CancerBone MetastasesNCT00156884Alberta Health services58
招募中
不适用
Surgical peri-implantitis treatment: regenerative approach and adjuvant antibiotic interventioNL-OMON27505niversity Medical Center Groningen123
未知
不适用
Inhibition of osteogenesis for the treatment of craniosynostosis by using new biomaterials.JPRN-UMIN000025379Tokyo Medical and Dental University15
进行中（未招募）
1 期
RANKL-blockade for the treatment of erosive osteoarthritis (OA) of interphalangeal finger jointsRandomized, double blind, placebo-controlled study to evaluate the efficacy of denosumab 60mg sc every 3 months in patients with erosive osteoarthritis of the interphalangeal finger jointsEUCTR2015-003223-53-BEGhent University Hospital100